J-code: Drugs administered other than oral method; chemotherapy drugs Drugs administered other than oral method; chemotherapy drugs
1,255 codes
Billing context
J-codes are permanent national codes for drugs and biologicals — most often clinician-administered (buy-and-bill) products paid under Medicare Part B — plus certain immunosuppressive, inhalation (via DME), and oral anticancer/antiemetic drugs. Units are reported in multiples of the dosage in the code descriptor.
| Code | Long descriptor | Payment limit (Q4 2026) | Added | Status |
|---|---|---|---|---|
| J7500 | Azathioprine, oral, 50 mg | $0.103per 50 MG | Jan 1, 1988 | Active |
| J7501 | Azathioprine, parenteral, 100 mg | — | Jan 1, 1988 | Active |
| J7502 | Cyclosporine, oral, 100 mg | $1.455per 100 MG | Jan 1, 2000 | Active |
| J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg | $1.863per 0.25 MG | Jan 1, 2016 | Active |
| J7504 | Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg | $5,509.072per 250 MG | Jan 1, 1988 | Active |
| J7505 | Muromonab-cd3, parenteral, 5 mg | — | Jan 1, 1988 | Ended Dec 31, 2025 |
| J7506 | Prednisone, oral, per 5 mg | — | Jan 1, 1989 | Ended Dec 31, 2015 |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | $0.162per 1 MG | Jan 1, 1995 | Active |
| J7508 | Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg | $0.604per 0.1 MG | Jan 1, 2014 | Active |
| J7509 | Methylprednisolone oral, per 4 mg | $0.128per 4 MG | Jan 1, 1996 | Active |
| J7510 | Prednisolone oral, per 5 mg | $0.498per 5 MG | Jan 1, 1996 | Active |
| J7511 | Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg | $1,065.837per 25 MG | Jan 1, 2002 | Active |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | $0.004per 1 MG | Jan 1, 2016 | Active |
| J7513 | Daclizumab, parenteral, 25 mg | — | Jan 1, 1999 | Ended Dec 31, 2025 |
| J7514 | Mycophenolate mofetil (myhibbin), oral suspension, 100 mg | — | Jan 1, 2025 | Ended Sep 30, 2026 |
| J7515 | Cyclosporine, oral, 25 mg | $0.576per 25 MG | Jan 1, 2000 | Active |
| J7516 | Injection, cyclosporine, 250 mg | $75.649per 250 MG | Jan 1, 2000 | Active |
| J7517 | Mycophenolate mofetil, oral, 250 mg | — | Jan 1, 2000 | Ended Sep 30, 2026 |
| J7518 | Mycophenolic acid, oral, 180 mg | $0.257per 180 MG | Jan 1, 2005 | Active |
| J7519 | Injection, mycophenolate mofetil, 10 mg | — | Oct 1, 2023 | Ended Sep 30, 2026 |
| J7520 | Sirolimus, oral, 1 mg | $0.609per 1 MG | Jan 1, 2001 | Active |
| J7521 | Tacrolimus, granules, oral suspension, 0.1 mg | $1.328per 0.1 MG | Apr 1, 2025 | Active |
| J7524 | Mycophenolate mofetil, oral, 5 mg | $0.002per 5 MG | Oct 1, 2026 | Active |
| J7525 | Tacrolimus, parenteral, 5 mg | $242.073per 5 MG | Jan 1, 2001 | Active |
| J7526 | Injection, mycophenolate mofetil, 5 mg | $0.200per 5 MG | Oct 1, 2026 | Active |
| J7527 | Everolimus, oral, 0.25 mg | $1.126per 0.25 MG | Jan 1, 2013 | Active |
| J7528 | Mycophenolate mofetil, for suspension, oral, 100 mg | — | Jan 1, 2026 | Ended Sep 30, 2026 |
| J7529 | Mycophenolate mofetil, for suspension, oral, 5 mg | $0.034per 5 MG | Oct 1, 2026 | Active |
| J7530 | Mycophenolate mofetil (myhibbin), oral suspension, 5 mg | $0.115per 5 MG | Oct 1, 2026 | Active |
| J7531 | Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg | — | Oct 1, 2026 | Active |
| J7599 | Immunosuppressive drug, not otherwise classifiedNOC / NOS | — | Jan 1, 1996 | Active |
| J7601 | Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg | $52.117per 3 MG | Jan 1, 2025 | Active |
| J7604 | Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram | — | Jan 1, 2008 | Active |
| J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms | $0.542per 15 mcg | Jan 1, 2008 | Active |
| J7606 | Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms | $1.373per 20 MCG | Jan 1, 2009 | Active |
| J7607 | Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg | — | Jan 1, 2007 | Active |
| J7608 | Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram | $6.398per 1 GM | Jan 1, 2000 | Active |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | — | Jan 1, 2007 | Active |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | — | Jan 1, 2007 | Active |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | $0.206per 1 MG | Jan 1, 2005 | Active |
| J7612 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | $0.304per 0.5 MG | Jan 1, 2005 | Active |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | $0.066per 1 MG | Jan 1, 2005 | Active |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | $0.076per 0.5 MG | Jan 1, 2005 | Active |
| J7615 | Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg | — | Jan 1, 2007 | Active |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | $0.197per 2.5 MG/0.5 MG | Jan 1, 2006 | Active |
| J7622 | Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | — | Jan 1, 2002 | Active |
| J7624 | Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | — | Jan 1, 2002 | Active |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | $0.923per 0.5 MG | Jan 1, 2002 | Active |
| J7627 | Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg | — | Jan 1, 2006 | Active |
| J7628 | Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | — | Jan 1, 2000 | Active |
| J7629 | Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | — | Jan 1, 2000 | Active |
| J7631 | Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams | $0.385per 10 MG | Jan 1, 2000 | Active |
| J7632 | Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams | — | Jan 1, 2008 | Active |
| J7633 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram | — | Jan 1, 2003 | Active |
| J7634 | Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram | — | Jan 1, 2007 | Active |
| J7635 | Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | — | Jan 1, 2000 | Active |
| J7636 | Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | — | Jan 1, 2000 | Active |
| J7637 | Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | — | Jan 1, 2000 | Active |
| J7638 | Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | — | Jan 1, 2000 | Active |
| J7639 | Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | $56.806per 1 MG | Jan 1, 2000 | Active |
| J7640 | Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms | — | Jan 1, 2006 | Active |
| J7641 | Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram | — | Jan 1, 2002 | Active |
| J7642 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | — | Jan 1, 2000 | Active |
| J7643 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | — | Jan 1, 2000 | Active |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | $0.445per 1 MG | Jan 1, 2000 | Active |
| J7645 | Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | — | Jan 1, 2007 | Active |
| J7647 | Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | — | Jan 1, 2007 | Active |
| J7648 | Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram | — | Jan 1, 2000 | Active |
| J7649 | Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | — | Jan 1, 2000 | Active |
| J7650 | Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | — | Jan 1, 2007 | Active |
| J7657 | Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | — | Jan 1, 2007 | Active |
| J7658 | Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram | — | Jan 1, 2000 | Active |
| J7659 | Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | — | Jan 1, 2000 | Active |
| J7660 | Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | — | Jan 1, 2007 | Active |
| J7665 | Mannitol, administered through an inhaler, 5 mg | — | Jan 1, 2012 | Active |
| J7667 | Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams | — | Jan 1, 2007 | Active |
| J7668 | Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams | — | Jan 1, 2000 | Active |
| J7669 | Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams | — | Jan 1, 2000 | Active |
| J7670 | Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams | — | Jan 1, 2007 | Active |
| J7674 | Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg | $1.766per 1 MG | Jan 1, 2005 | Active |
| J7676 | Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg | — | Jan 1, 2008 | Active |
| J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram | $0.200per 1 MCG | Jul 1, 2019 | Active |
| J7680 | Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | — | Jan 1, 2000 | Active |
| J7681 | Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | — | Jan 1, 2000 | Active |
| J7682 | Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams | $11.404per 300 MG | Jan 1, 2000 | Active |
| J7683 | Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | — | Jan 1, 2000 | Active |
| J7684 | Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | — | Jan 1, 2000 | Active |
| J7685 | Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams | — | Jan 1, 2007 | Active |
| J7686 | Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg | $830.383per 1.74 MG | Jan 1, 2011 | Active |
| J7699 | Noc drugs, inhalation solution administered through dmeNOC / NOS | — | Jan 1, 1993 | Active |
| J7799 | Noc drugs, other than inhalation drugs, administered through dmeNOC / NOS | — | Jan 1, 1993 | Active |
| J7999 | Compounded drug, not otherwise classifiedNOC / NOS | — | Jan 1, 2016 | Active |
| J8498 | Antiemetic drug, rectal/suppository, not otherwise specifiedNOC / NOS | — | Jan 1, 2006 | Active |
| J8499 | Prescription drug, oral, non chemotherapeutic, nosNOC / NOS | — | Jan 1, 1995 | Active |
| J8501 | Aprepitant, oral, 5 mg | $2.511per 5 MG | Jan 1, 2005 | Active |
| J8502 | Injection, aprepitant (aponvie), 1 mg | $1.998per 1 MG | Apr 1, 2026 | Active |
| J8510 | Busulfan; oral, 2 mg | — | Jan 1, 2000 | Active |
| J8515 | Cabergoline, oral, 0.25 mg | $0.337per 0.25 MG | Jan 1, 2006 | Active |
| J8520 | Capecitabine, oral, 150 mg | — | Jan 1, 2000 | Ended Sep 30, 2024 |
| J8521 | Capecitabine, oral, 500 mg | — | Jan 1, 2000 | Ended Sep 30, 2024 |